GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

Dr. Salim Yusuf MBBS, DPHIL, FRCPC, FRSC, O.C.

Photo of Salim Yusuf
Salim Yusuf Dr.
Executive Director

Current Positions

  • Executive Director – Population Health Research Institute
  • Distinguished University Professor of Medicine – McMaster University
  • Heart and Stroke Foundation of Ontario / Marion W. Burke Chair in Cardiovascular Disease
  • Joint Member, Department of Health Research Methods, Evidence, and Impact (HEI)
  • Chief Scientist, Hamilton Health Sciences
  • Past President, World Heart Federation

Bio

Salim Yusuf, Distinguished University Professor of Medicine, and Executive Director of the Population Health Research Institute, McMaster University and Chief Scientist, Hamilton Health Sciences.

Salim Yusuf is an internationally renowned cardiologist and epidemiologist, whose work over 40 years has substantially influenced prevention and treatment of cardiovascular disease. Born in India, medically qualified at St. John’s Medical College, Bangalore in 1976, he received a Rhodes Scholarship and obtained a DPhil from Oxford, during which he (along with Richard Peto, Rory Collins and Peter Sleight) initiated the concepts of large, simple trials, and meta-analysis. He proposed the concept of combination drug treatment for prevention of CVD to achieve large reductions in CVD with a single pill (now called the polypill concept), but more importantly has been evaluating the concept through large randomized trials. He leads several global studies involving >60 countries in every inhabited continent of the world aimed at enhancing knowledge about the biological, behavioural and societal causes, consequences, and approaches to control of heart diseases, and strokes through large multi-country programs such as INTERHEART, INTERSTROKE, PURE and most recently the million person surveillance program with the Government of Kerala –aimed at controlling CVD and other NCDs in a state of 34 million people— KIRAN.

He holds a Heart and Stroke Foundation of Ontario Research Chair and has received (among others) the Lifetime Research Achievement award of the Canadian Cardiovascular Society; the Paul Wood Silver Medal of the British Cardiac Society; the European Society of Cardiology gold medal, the clinical Research Prize of the American Heart Association and the International Award and the Braunwald Lecture of the American College of Cardiology. He has been inducted into the Royal Society of Canada and the Canadian Medical Hall of Fame; been appointed as an Officer of the Order of Canada, and received the Canada Gairdner Wightman Award in 2014.

He has published more than 1,000 articles in refereed journals, rising to the second most cited researcher in the world for 2011. He has mentored over 120 scientists, several of whom are in leadership positions across the globe. He has been President of the World Heart Federation (2015-2016), where had initiated several programs (the Emerging Leaders program, road maps for CVD control and a course for training primary care practitioners in CVD prevention) aimed at halving the CVD burden globally within a generation.

  • Atrial Fibrillation trials
  • BENEFIT
  • COMPASS
  • HOPE series of trials
  • IMPI
  • INTERHEART
  • INTERSTROKE
  • KIRAN
  • OASIS series of trials
  • PURE

Publications are listed in chronological order by descending date. Link takes user to pubMed for publication details.